Trelagliptin 25 mg
SYR-472-3003
Phase 3 small_molecule completed
Quick answer
Trelagliptin 25 mg for Type 2 Diabetes Mellitus is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed